Bioimpedance, respiratory health and inflammation in adults with Cystic Fibrosis: a prospective observational study

• Conditions: ung Diseases; Cystic Fibrosis

• Registration Number: RBR-10w3x7r3
• Lead Sponsor: Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da USP

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-10-31
• Last Update Posted: 13 November 2023
• Study Completion: 2029-11-20

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Adults of both genders; aged 18 to 59; with Cystic Fibrosis; under the care of a specialized outpatient clinic at a tertiary hospital

Exclusion Criteria

Comorbidities characterized by systemic low-grade chronic inflammation or malabsorptive syndromes, except for those secondary to Cystic Fibrosis; malignant neoplasm; edema; chronic kidney disease with glomerular filtration rate less than 60 mg/dL; end-stage organ failure; amputated limbs; gastric or intestinal resections; implanted cardiac devices; chronic use of oral immunosuppressants or anti-inflammatory drugs; initiation of diuretic use or dose modification 3 months prior to recruitment; pulmonary exacerbations within 3 months of recruitment; ethical restrictions that prevent proper consent for study participation; women who are pregnant or breastfeeding

Study & Design

• Study Type: Observational
• Study Design: Not specified